CD200: A putative therapeutic target in cancer

Biochemical and Biophysical Research Communications

Volumn 366, Issue 1, 2008, Pages 117-122

  Moreaux, Jérôme ^a,b   Veyrune, Jean Luc ^a   Reme, Thierry ^a,b   De Vos, John ^a,b,c   Klein, Bernard ^a,b,c  

^a HÔPITAL SAINT ELOI   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

CD200; Cell surface molecules; Therapeutic target; Tolerance; Tumor immunity

Indexed keywords

CD200 ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CHRONIC LYMPHATIC LEUKEMIA; COLON CARCINOMA; GENE EXPRESSION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; KIDNEY CARCINOMA; MALIGNANT MESOTHELIOMA; MICROARRAY ANALYSIS; MYELOMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; REFERENCE DATABASE; TESTIS CARCINOMA; TISSUE MICROARRAY;

CERAMICS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 37349071767     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.103     Document Type: Article

References (36)

1. Tonks A., Hills R., White P., Rosie B., Mills K.I., Burnett A.K., and Darley R.L. CD200 as a prognostic factor in acute myeloid leukaemia. Leukemia 21 (2007) 566-568
2. Barclay A.N., Wright G.J., Brooke G., and Brown M.H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23 (2002) 285-290
3. Wright G.J., Cherwinski H., Foster-Cuevas M., Brooke G., Puklavec M.J., Bigler M., Song Y., Jenmalm M., Gorman D., McClanahan T., Liu M.R., Brown M.H., Sedgwick J.D., Phillips J.H., and Barclay A.N. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171 (2003) 3034-3046
4. Gorczynski R.M. CD200 and its receptors as targets for immunoregulation. Curr. Opin. Investig. Drugs 6 (2005) 483-488
5. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., and Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (2000) 1768-1771
6. Jenmalm M.C., Cherwinski H., Bowman E.P., Phillips J.H., and Sedgwick J.D. Regulation of myeloid cell function through the CD200 receptor. J. Immunol. 176 (2006) 191-199
7. Gorczynski R.M., Lee L., and Boudakov I. Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R. Transplantation 79 (2005) 1180-1183
8. Gorczynski L., Chen Z., Hu J., Kai Y., Lei J., Ramakrishna V., and Gorczynski R.M. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J. Immunol. 162 (1999) 774-781
9. Gorczynski R.M., Chen Z., Fu X.M., and Zeng H. Increased expression of the novel molecule OX-2 is involved in prolongation of murine renal allograft survival. Transplantation 65 (1998) 1106-1114
10. Gorczynski R.M., Cohen Z., Fu X.M., and Lei J. Anti-rat OX-2 blocks increased small intestinal transplant survival after portal vein immunization. Transplant. Proc. 31 (1999) 577-578
11. McWhirter J.R., Kretz-Rommel A., Saven A., Maruyama T., Potter K.N., Mockridge C.I., Ravey E.P., Qin F., and Bowdish K.S. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proc. Natl. Acad. Sci. USA 103 (2006) 1041-1046
12. Kretz-Rommel A., Qin F., Dakappagari N., Ravey E.P., McWhirter J., Oltean D., Frederickson S., Maruyama T., Wild M.A., Nolan M.J., Wu D., Springhorn J., and Bowdish K.S. CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy. J. Immunol. 178 (2007) 5595-5605
13. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., and Chinnaiyan A.M. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. USA 101 (2004) 9309-9314
14. Assou S., Lecarrour T., Tondeur S., Strom S., Gabelle A., Marty S., Nadal L., Pantesco V., Reme T., Hugnot J.P., Gasca S., Hovatta O., Hamamah S., Klein B., and De Vos J. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25 (2007) 961-973
15. Elfilali A., Lair S., Verbeke C., La Rosa P., Radvanyi F., and Barillot E. ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res. 34 (2006) D613-D616
16. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., and Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1-6
17. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., and Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101 (2004) 6062-6067
18. Shyamsundar R., Kim Y.H., Higgins J.P., Montgomery K., Jorden M., Sethuraman A., van de Rijn M., Botstein D., Brown P.O., and Pollack J.R. A DNA microarray survey of gene expression in normal human tissues. Genome Biol. 6 (2005) R22
19. Moreaux J., Hose D., Reme T., Jourdan E., Hundemer M., Legouffe E., Moine P., Bourin P., Moos M., Corre J., Mohler T., De Vos J., Rossi J.F., Goldschmidt H., and Klein B. CD200 is a new prognostic factor in multiple myeloma. Blood 108 (2006) 4194-4197
20. Lenburg M.E., Liou L.S., Gerry N.P., Frampton G.M., Cohen H.T., and Christman M.F. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 3 (2003) 31
21. Ginos M.A., Page G.P., Michalowicz B.S., Patel K.J., Volker S.E., Pambuccian S.E., Ondrey F.G., Adams G.L., and Gaffney P.M. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 64 (2004) 55-63
22. Korkola J.E., Houldsworth J., Chadalavada R.S., Olshen A.B., Dobrzynski D., Reuter V.E., Bosl G.J., and Chaganti R.S. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66 (2006) 820-827
23. Skotheim R.I., Lind G.E., Monni O., Nesland J.M., Abeler V.M., Fossa S.D., Duale N., Brunborg G., Kallioniemi O., Andrews P.W., and Lothe R.A. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res. 65 (2005) 5588-5598
24. Gordon G.J., Rockwell G.N., Jensen R.V., Rheinwald J.G., Glickman J.N., Aronson J.P., Pottorf B.J., Nitz M.D., Richards W.G., Sugarbaker D.J., and Bueno R. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am. J. Pathol. 166 (2005) 1827-1840
25. Zou T.T., Selaru F.M., Xu Y., Shustova V., Yin J., Mori Y., Shibata D., Sato F., Wang S., Olaru A., Deacu E., Liu T.C., Abraham J.M., and Meltzer S.J. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21 (2002) 4855-4862
26. Zhan F., Barlogie B., Arzoumanian V., Huang Y., Williams D.R., Hollmig K., Pineda-Roman M., Tricot G., van Rhee F., Zangari M., Dhodapkar M., and Shaughnessy Jr. J.D. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 109 (2007) 1692-1700
27. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H., Freedman A., Inghirami G., Cro L., Baldini L., Neri A., Califano A., and Dalla-Favera R. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194 (2001) 1625-1638
28. Modlich O., Prisack H.B., Pitschke G., Ramp U., Ackermann R., Bojar H., Vogeli T.A., and Grimm M.O. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin. Cancer Res. 10 (2004) 3410-3421
29. Sanchez-Carbayo M., Socci N.D., Lozano J., Saint F., and Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24 (2006) 778-789
30. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., and Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98 (2001) 13790-13795
31. Radich J.P., Dai H., Mao M., Oehler V., Schelter J., Druker B., Sawyers C., Shah N., Stock W., Willman C.L., Friend S., and Linsley P.S. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA 103 (2006) 2794-2799
32. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., Jatkoe T., Berns E.M., Atkins D., and Foekens J.A. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
33. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., and Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
34. Haqq C., Nosrati M., Sudilovsky D., Crothers J., Khodabakhsh D., Pulliam B.L., Federman S., Miller III J.R., Allen R.E., Singer M.I., Leong S.P., Ljung B.M., Sagebiel R.W., and Kashani-Sabet M. The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. USA 102 (2005) 6092-6097
35. Tomlins S.A., Mehra R., Rhodes D.R., Cao X., Wang L., Dhanasekaran S.M., Kalyana-Sundaram S., Wei J.T., Rubin M.A., Pienta K.J., Shah R.B., and Chinnaiyan A.M. Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39 (2007) 41-51
36. Kawasaki B.T., Mistree T., Hurt E.M., Kalathur M., and Farrar W.L. Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochem. Biophys. Res. Commun. (2007) 778-782